Veyong, a subsidiary of Limin, was shortlisted for two honor lists successively
Recently, Limin expressed that Veyong, a subsidiary company, was successfully selected into the 2023 list of top 100 innovative enterprises in Hebei Province's strategic emerging industries, ranking 51st. In addition, Veyong was recently identified by the Shijiazhuang Science and Technology Bureau as the leading enterprise of science and technology in Shijiazhuang in 2023
On November 7, with the joint support of the Hebei Development and Reform Commission, the Provincial Science and Technology Department, the Provincial Industry and Information Technology Department, and the Provincial Market Supervision Bureau, the Hebei High-tech Industry Association released the 2023 list of top 100 innovative enterprises in Hebei Province's strategic emerging industries, and Veyong, a subsidiary of Limin, was successfully selected, ranking 51st.
The selection is based on the weighted ranking of the company's 2022 business income, the number of authorized patents, the number of authorized invention patents and other indicators, and after consulting the provincial Development and Reform Commission and other guiding units, they got the final determination. The selected enterprises are the backbone enterprises of strategic emerging industries in Hebei Province, and are also the core forces to carry out technological innovation and break through key technologies in the industry, which plays an important supporting role in the construction of a modern industrial system and the realization of high-quality economic development in the province.
Shijiazhuang science and technology innovation work leading group issued the 2023 Shijiazhuang science and technology leading enterprises identification notice, the city only 15 enterprises on the list. Veyong, was identified as a leading enterprise of science and technology in Shijiazhuang by Shijiazhuang Science and Technology Bureau. The leading enterprise of science and technology is the highest honor of science and technology enterprises in Hebei Province, and is an important support of the national strategic science and technology force. The enterprise's scientific innovation ability, leading role, economic scale, global competitiveness and other aspects are evaluated by comprehensive consideration.
Over the years, Veyong has continuously improved its scientific and technological innovation ability, strengthened the construction of personnel training system, won the National enterprise Technology Center, Hebei Province science and technology innovation demonstration enterprise, and a number of scientific and technological innovation achievements, highlighting the comprehensive strength of Veyong in scientific and technological innovation and the significant role of relying on scientific and technological innovation to the development of enterprises. Innovation leads, technology enables.
As an advanced production enterprise in the green bio-pesticide industry, Veyong has always adhered to its corporate mission, actively practiced the concept of innovative development, constantly improved the level of independent innovation, won a number of honors, obtained 10 national and provincial scientific and technological achievements, obtained 97 patents, and participated in the formulation of 24 international standards, national industries, industry standards, etc. It has made good achievements in scientific and technological achievements, intellectual property creation, and standard setting.
In the future, Veyong will continue to implement the concept of innovative development, increase the intensity of product research and development and innovation, constantly strengthen product quality, and enhance core competitiveness. Further enhance the capacity of independent innovation, gather all kinds of factor resources, promote the deep integration of innovation chain and industrial chain, anchor the direction of high-end, intelligent and green products, create a series of products such as Avermectin, Emamectin Benzoate, and Glufosinate-P, accelerate the construction of efficient and full load, new product incubation base, focus on core key technologies, and layout of cutting-edge technologies in the industry. Contribute to promoting the high-quality development of the group.
2026-08-14
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Limin Shares to build a synthetic biology laboratory, focusing on the layout of 'biosynthesis' products
-
Limin Shares to build a synthetic biology laboratory, focusing on the layout of 'biosynthesis' products
-
Invest 45 million! Lier (Hunan) plans to build 100,000 tons of green plant protection formulation project (Glufosinate-P)
-
China agrochemical industry weekly(0531)
-
Wynca’s 20,000 tons of Glufosinate-P industrial project (Phase I) trial production
-
China:The price of Glufosinate ammonium TK hit a new low in ten years
-
The US EPA intends to register a new herbicide active ingredient, Glufosinate-P
-
Limin: phase 1 of Glufosinate-P 2000 tons project passed the trial production acceptance
-
Notice: The wheat spiders are about to appear in large numbers
-
China agrochemical industry weekly(0308)
Recommend Reading
-
Dover to Acquire Cloeren and Expand Its Polymer-Extrusion Equipment Portfolio
-
Ashland Q3 Sales Drop 15 Percent but EBITDA Margin Holds at 24.4 Percent Self-Help Actions Boost Outlook
-
Huntsman Issues Two Consecutive MDI Price Hike Notices: €250 Increase in Europe, $300 Increase in India
-
Pirelli H1 Revenue Hits €3.5 Billion Net Income Up 14 Percent High-Value Tire Sales Surge to 80 Percent
-
BASF Ludwigshafen Workforce Falls Below 30,000, Lowest Level in 72 Years
-
PVC Market Prices Fluctuate and Decline Under Dual Supply and Demand Pressures
-
Since late July, the Chinese natural rubber market has fluctuated and weakened
-
EFSA’s Updated Food-Additive Application Guidance Takes Effect
-
India Approves ₹30.3 Billion Chemical-Park Scheme to Build Three Mega Industrial Hubs
-
FDA Revokes Orange B Authorization and Proposes Removing Citrus Red No. 2